Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 694 34 610.1 |
96 | EP file number | EAKZ | 03 01 5590.7 |
97 | EP publication number | EPN | 1366771 |
54 | Designation/title | TI | Verwendung der neurotoxischen Komponente des Botulinum Toxins zur Behandlung von Muskelspasmen |
51 | IPC main class | ICM (ICMV) | A61K 38/48 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 21/02 (2006.01) |
22 | DE application date | DAT | Dec 16, 1994 |
96 | EP application date | EAT | Dec 16, 1994 |
43 | Date of first publication | OT | Dec 3, 2003 |
| Date of publication of grant | PET | Mar 26, 2008 |
71/73 | Applicant/owner | INH | Allergan, Inc., Irvine, Calif., US; Merz Pharma GmbH & Co. KGaA, 60318 Frankfurt, DE |
72 | Inventor | IN | Aoki, K Roger, Coto de Caza, CA 92679, US; Grayston, Michael W, Irvine, CA 92714, US; Carlson, Steven R, Laguna Niguel, CA 92677, US; Leon, Judith M, Laguna Niguel, CA 92677, US |
74 | Representative | VTR | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069434610T2 Searchable text:
DE000069434610T2 |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 173996 Dec 28, 1993
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 12 2008 000 042.4 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | DE, ES, FR, GB, IT |
| Published EP/WO documents | EPWOPN | Original document:
EP000001366771 Searchable text:
EP000001366771 Original document:
EP000001366771B1 Searchable text:
EP000001366771B1 |
43 | Date of first publication | EVT | Dec 3, 2003 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 30, 2022 (Show all update days)(Hide all update days)- Apr 30, 2022; Aug 13, 2021; Aug 9, 2018; Jul 3, 2018; Jan 19, 2017; Oct 23, 2015; Aug 13, 2015; Jul 9, 2015; Mar 31, 2015; Feb 26, 2015; Dec 18, 2014; Jan 18, 2014; Feb 2, 2013; Jan 9, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 25, 2008 |
| Issue number | HN | 39 |
| Year | PJ | 2008 |
| Publication date | VT | Sep 25, 2008 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Allergan, Inc., Irvine, Calif., US; Merz Pharma GmbH & Co. KGaA, 60318 Frankfurt, DE |
71/73 | Previous applicant/owner | INHF | Allergan, Inc., Irvine, Calif., US |